Canada · Delayed Price · Currency is CAD Britannia Life Sciences Statistics
Total Valuation
CSE:BLAB has a market cap or net worth of CAD 11.52 million. The enterprise value is -681,260.
| Market Cap | 11.52M |
| Enterprise Value | -681,260 |
Important Dates
The next estimated earnings date is Friday, November 27, 2026.
| Earnings Date | Nov 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:BLAB has 164.59 million shares outstanding.
| Current Share Class | 164.59M |
| Shares Outstanding | 164.59M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 38.82% |
| Owned by Institutions (%) | n/a |
| Float | 100.69M |
Valuation Ratios
The trailing PE ratio is 0.76.
| PE Ratio | 0.76 |
| Forward PE | n/a |
| PS Ratio | 28.35 |
| PB Ratio | 0.52 |
| P/TBV Ratio | 0.52 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.69, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.69 |
| Quick Ratio | 5.49 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.54 |
| Interest Coverage | -67.07 |
Financial Efficiency
Return on equity (ROE) is 108.44% and return on invested capital (ROIC) is -20.53%.
| Return on Equity (ROE) | 108.44% |
| Return on Assets (ROA) | -5.24% |
| Return on Invested Capital (ROIC) | -20.53% |
| Return on Capital Employed (ROCE) | -6.52% |
| Weighted Average Cost of Capital (WACC) | 3.97% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 28 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CSE:BLAB has paid 507,837 in taxes.
| Income Tax | 507,837 |
| Effective Tax Rate | 3.28% |
Stock Price Statistics
The stock price has increased by +7.69% in the last 52 weeks. The beta is -0.07, so CSE:BLAB's price volatility has been lower than the market average.
| Beta (5Y) | -0.07 |
| 52-Week Price Change | +7.69% |
| 50-Day Moving Average | 0.07 |
| 200-Day Moving Average | 0.09 |
| Relative Strength Index (RSI) | 50.86 |
| Average Volume (20 Days) | 148,614 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CSE:BLAB had revenue of CAD 406,436 and earned 16.54 million in profits. Earnings per share was 0.10.
| Revenue | 406,436 |
| Gross Profit | 92,795 |
| Operating Income | -1.45M |
| Pretax Income | 15.47M |
| Net Income | 16.54M |
| EBITDA | -1.39M |
| EBIT | -1.45M |
| Earnings Per Share (EPS) | 0.10 |
Balance Sheet
The company has 12.41 million in cash and 211,517 in debt, with a net cash position of 12.20 million or 0.07 per share.
| Cash & Cash Equivalents | 12.41M |
| Total Debt | 211,517 |
| Net Cash | 12.20M |
| Net Cash Per Share | 0.07 |
| Equity (Book Value) | 22.05M |
| Book Value Per Share | 0.13 |
| Working Capital | 11.93M |
Cash Flow
| Operating Cash Flow | -389,947 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 62,973 |
| Net Borrowing | -105,551 |
| Free Cash Flow | -389,947 |
| FCF Per Share | -0.00 |
Margins
Gross margin is 22.83%, with operating and profit margins of -357.47% and 4,069.61%.
| Gross Margin | 22.83% |
| Operating Margin | -357.47% |
| Pretax Margin | 3,806.56% |
| Profit Margin | 4,069.61% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:BLAB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 143.57% |
| FCF Yield | -3.38% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 18, 2021. It was a reverse split with a ratio of 0.1.
| Last Split Date | Nov 18, 2021 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
CSE:BLAB has an Altman Z-Score of 3.65 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.65 |
| Piotroski F-Score | 3 |